The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these studies. There are some that feel that only a randomized clinical trial can produce robust study results that are scientifically sound and provide relevant data for sponsors and regulatory authorities. Within this podcast we will explore the scientific integrity of post-marketing and observational research, and how these studies can provide important information that can complement your early phase clinical trial results.
Is Marijuana a Replacement for Opioids?
THE INSIGHT SERIES: Can you use the same outsourcing methodologies for post-marketing studies as pre-approval research? - Part 4
As the number of preferred provider relationships grow and become more sophisticated, budget grids and assumptions must align with the needs of…
Meeting Enrollment Goals Breast Cancer
An open-label, randomized, multi-center study to evaluate the use of Study Drug in the prevention of cancer treatment-related bone loss in…